CD4 and digestive system neoplasm: However, we found that the frequency of ST2L-expressing CD4+ cells was increased in liver granuloma (10 ± 2% of CD4+ cells vs 0.6 ± 0.1% in control livers) with no significant upregulation in the spleen (data not shown).